Spotlight on… Single use
Posted: 10 September 2018 | Merck | No comments yet
In this Spotlight on Single Use, David Beattie, Vice President BioProcessing R&D, Merck explains the mode of operation and benefits of its Pellicon® Capsules…
What new single-use processing device is your company offering? Merck offers Pellicon® Capsules: novel single-use tangential flow filtration (TFF) devices engineered for ease-of-use, process flexibility and improved product and operator safety in manufacturing monoclonal antibodies, antibody-drug conjugates and other biologics. These efficient, spiral-wound TFF filters perform like Pellicon® cassettes, complementing our many products and services related to TFF and ensuring the quality, availability and safety of life‑enhancing drugs.
The rest of this spotlight is restricted - login or subscribe free to access
Thank you for visiting our website. To access this content in full you'll need to login. It's completely free to subscribe, and in less than a minute you can continue reading. If you've already subscribed, great - just login.
Why subscribe? Join our growing community of thousands of industry professionals and gain access to:
- bi-monthly issues in print and/or digital format
- case studies, whitepapers, webinars and industry-leading content
- breaking news and features
- our extensive online archive of thousands of articles and years of past issues
- ...And it's all free!
Click here to Subscribe today Login here
